Cooperative Agreement U01DP006935
Award Date 9/30/26
Completion Date 9/29/30
Dollars Obligated $419K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Boston, MA, USA
Similar Awards
- The Centers for Disease Control and Prevention awarded a $697,674 Cooperative Agreement to The General Hospital Corporation (doing business as Massachusetts General Hospital) on September 30, 2025, under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136). The award supports research examining high-dose medications for opioid use disorder and their effects on treatment retention, drug use patterns, and overdose risks amid the fentanyl crisis. Work is...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a cooperative agreement totaling $497,921 to The Children's Hospital of Philadelphia on September 30, 2026, under the Centers for Disease Control and Prevention Investigations and Technical Assistance program (CFDA 93.283). The award funds innovations in elucidating the epidemiology of childhood epilepsy using PEDSnet, a national pediatric learning system. Work is performed in Philadelphia,...
- The National Institute of Neurological Disorders and Stroke awarded the Epilepsy Foundation of America $491,786 on September 15, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to plan epilepsy health disparities research through community co-production. The recipient will develop methods to engage local community partners and epilepsy patient and family partners in co-producing research priorities for epilepsy health disparities...
- This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $320,000.00 in funding to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on "GAMMA DELTA T CELL LIGANDS IN MS". The award period runs from November 1, 2024 to October 31, 2026. As a major recipient of federal research funding, MGH will leverage its extensive...
- The National Institute of Neurological Disorders and Stroke, part of the Department of Health and Human Services National Institutes of Health, awarded The General Hospital Corporation (Massachusetts General Hospital) $234,070 on September 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds a five-year mentored patient-oriented research career development program (K23 mechanism) investigating how direct electrical...
- The Department of the Army Medical Command awarded a $503,599 Project Grant to Massachusetts General Hospital through the Military Medical Research and Development program. The grant will fund research from June 1, 2022 to May 31, 2025 to exploit thalamocortical interactions for seizure termination in multifocal epilepsy. As part of the Military Medical Research and Development program's goal of transforming health care through innovative medical research, this award will support Massachusetts...
- The federal Project Grant award in the amount of $999,940.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for the project "DEVELOPMENT OF IMAGING OUTCOME MEASURES OF NEUROPROTECTION IN MULTIPLE SCLEROSIS USING ULTRA-HIGH GRADIENT DIFFUSION MRI". The award period is from June 1, 2024 to May 31, 2027. Through this grant, MGH...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $1,865,846 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on July 1, 2024. The funding will support the project "TARGETING NEUROIMMUNE AND EPITHELIAL SIGNALING FOR ECZEMA TREATMENT" through June 30, 2028. MGH, a leading academic medical center and research institution, will conduct biomedical research,...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), has been awarded a $1,000,236.00 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, effective April 1, 2024 through March 31, 2028, will fund research to "UNLOCK THE CTDNA MUTATIONAL PATTERNS FOR EARLY CANCER DETECTION AND NONINVASIVE BIOMARKERS." As a leading academic medical center and research...
- The U.S. Defense Health Agency awarded The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a $1,140,766 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The award, effective September 1, 2024 through August 31, 2027, will fund a novel mHealth balance assessment and rehabilitation project using computer vision and AI for patients with neurofibromatosis type 2 (NF2). MGH, as the primary research institution, will...